ROLE OF RAKTAMOKSHANA AND SHAMANA CHIKITSA IN RAKTA PRADOSHAJA VYADHI: A CASE REPORT

*Dr. Rucha Bhalchandra Joshi, Prof. Dr. Vandana Anil Avhad, Prof. Dr. Maya Vivek Gokhale

ABSTRACT

• Background: Frequent use of over-the-counter (OTC) medications for symptomatic relief may contribute to chronic systemic disorders. In Ayurveda, suppression of the vomiting urge (Chhardi Vega) through the use of antiemetics or antacids may be considered a form of Vegavarodh, leading to vitiation of Pitta and Rakta and resulting in Rakta Pradoshaja Vyadhi.
• Aim: To evaluate the clinical efficacy of Raktamokshana as a primary Shodhana therapy followed by Shamana Chikitsa in the management of Rakta Pradoshaja Vyadhi associated with Chhardi Vegavarodh as Nidana.
• Materials and Methods: A 49-year-old male presented with daily evening episodes of Sarvanga Raktavarni Mandalotpatti (generalized erythematous maculopapular rashes) with Tivra Kandu (severe itching) and Daha (burning sensation), Shool at Ubhay Shankha Pradesh (bitemporal headache), Asamadhankarak Malapravrutti (unsatisfactory bowel movements), and Adhmaan (flatulence). The patient had a history of chronic self-medication with OTC antacids and antiemetics for Gastroesophageal Reflux Disease (GERD) and Urdhvaga Amlapitta. The treatment protocol included Raktamokshana (Siravyadha) as Shodhana chikitsa, followed by oral Shamana medications for one month. Clinical assessment was carried out using standardized grading scales before and after treatment.
• Results: Significant improvement was observed in all symptoms following treatment. Objective symptom severity scores also showed marked reduction.
• Conclusion: Raktamokshana, combined with targeted Shamana therapy was found effective in the management of Pitta-Rakta dominant Rakta Pradoshaja Vyadhi associated with Chhardi Vegavarodh. The treatment provided significant symptomatic relief and improved the patient’s quality of life.

Keywords: Rakta Pradoshaja Vyadhi, Raktamokshana, Siravyadha, Chhardi Vegavarodh, Shodhana Chikitsa.